Login to Your Account

Indian regulator clears first autologous dendritic cell-based I-O product

By Haky Moon
Staff Writer

Tuesday, April 11, 2017

HONG KONG – In a country where just seven new oncology drugs were introduced in the last five years, the recent approval of Apac Biotech Pvt. Ltd.'s first-of-its-kind autoimmune therapy marked a significant step forward.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription